Pharmafile Logo
Pharmafocus logo
Advanced Search

Androlabs

Showing 3 posts of 3 posts found.

Androlabs receives UK authorisation for new Testavan presentation

September 4, 2026
Androlabs, Testavan, UK authorisation, hypogonadism, testosterone

Androlabs has received UK marketing authorisation for a new presentation of Testavan 4.6 mg/actuation transdermal gel for testosterone replacement therapy …

News

Androlabs and Majorelle expand testosterone therapy into France

August 4, 2026
Androlabs, Majorelle, hypogonadism, testosterone therapy

Androlabs has partnered with French men’s health specialist Majorelle to commercialise Testavan, a testosterone replacement therapy for adult men with …

News

Mind the gap: men’s health and the need for progress

May 12, 2025
Advocacy Development, Medical Communications, Medical Education, Research and Development Androlabs, Men's Health Strategy, Men's mental health, Movember Foundation, Pharmacy, Psychiatry, mental health

From prostate cancer to hormonal health, many areas of men’s health require more attention. As male life expectancy and healthy …

Feature
Thought Leadership
The Gateway to Local Adoption Series

Latest content

One in three UK women with migraine say symptoms taken less seriously

September 24, 2026

Report highlights scope to expand day surgery

September 23, 2026

Sygnature formalises drug discovery collaboration with X-Chem

September 22, 2026

Codis appoints Steven Facer as chief commercial officer

September 21, 2026

Danish medical cannabis use rises as regulator reports no new safety signals

September 21, 2026